Adverse event frequency
| Adverse event . | n . | % . |
|---|---|---|
| Nausea | 7 | 25.9 |
| Diarrhea | 5 | 18.5 |
| Rash | 5 | 14.8 |
| Abdominal pain | 3 | 11.1 |
| Blood creatinine increased | 3 | 11.1 |
| Alanine aminotransferase increased | 2 | 7.4 |
| Aspartate aminotransferase increased | 2 | 7.4 |
| Nasopharyngitis | 2 | 7.4 |
| Death* | 0 (2) | 7.4 |
| Adverse event . | n . | % . |
|---|---|---|
| Nausea | 7 | 25.9 |
| Diarrhea | 5 | 18.5 |
| Rash | 5 | 14.8 |
| Abdominal pain | 3 | 11.1 |
| Blood creatinine increased | 3 | 11.1 |
| Alanine aminotransferase increased | 2 | 7.4 |
| Aspartate aminotransferase increased | 2 | 7.4 |
| Nasopharyngitis | 2 | 7.4 |
| Death* | 0 (2) | 7.4 |
Both patients were off study at the time of death.